These answers draw in part from “Private Equity in Behavior Analysis: A Reckoning” by Cody Morris, Ph.D., BCBA-D, LBA (BehaviorLive), and extend it with peer-reviewed research from our library of 27,900+ ABA research articles. Clinical framing, BACB ethics code references, and cross-links below are synthesized by Behaviorist Book Club.
View the original presentation →Private equity ownership occurs when an investment firm purchases a controlling interest in an ABA service provider using pooled capital from institutional investors and wealthy individuals. The PE firm typically plans to increase the company's value over three to seven years through growth strategies such as acquiring smaller practices, expanding into new markets, and improving operational efficiency, then sells the company for a profit. The PE firm installs its own leadership or works closely with existing management to execute its growth plan. This model differs from traditional ownership structures where ABA companies were typically founded and operated by BCBAs or nonprofit organizations with a primary clinical rather than financial mission.
The impact varies significantly across organizations, but the financial pressure to grow revenue can translate into higher caseload expectations for BCBAs. Some PE-backed organizations establish productivity benchmarks that require BCBAs to supervise more clients than would be considered optimal for individualized care. Clinical autonomy may be influenced through indirect mechanisms such as performance metrics tied to billable hours, standardized treatment protocols that limit individualization, or organizational cultures that discourage questioning clinical directives from non-clinical leadership. However, some PE-backed organizations invest in clinical infrastructure that supports BCBA decision-making. The key is evaluating the specific practices of each organization rather than making blanket assumptions.
PE investment can bring genuine advantages. Capital infusion may fund technology development including better data collection platforms and electronic health records. Geographic expansion can increase access to services in underserved areas where families previously faced long waitlists or had no local providers. Centralized administrative support can reduce the non-clinical burden on BCBAs. Some PE-backed organizations invest significantly in training programs, research initiatives, and career development pathways that smaller practices cannot afford. The critical question is whether these investments genuinely improve clinical outcomes and practitioner experience, or whether they primarily serve the financial growth strategy of the PE firm.
The primary risks stem from misalignment between financial incentives and clinical needs. These include potential overauthorization of treatment hours to increase revenue, high staff turnover driven by cost reduction strategies, rapid expansion that outpaces quality assurance capabilities, and formulaic treatment approaches that sacrifice individualization for operational efficiency. When an organization's decision-makers are ultimately accountable to investment returns rather than client progress, the systems that protect clinical quality must be exceptionally robust. Without strong clinical governance structures, the pressure to grow revenue can gradually erode the individualized, data-driven approach that makes ABA effective.
Several provisions of the Ethics Code for Behavior Analysts are directly relevant. Code 2.01 requires providing effective treatment based on the best available evidence, which must remain the standard regardless of organizational pressures. Code 2.14 addresses conflicts of interest and obliges practitioners to identify situations where organizational financial interests might compromise clinical judgment. Code 1.05 concerns independent professional judgment, requiring BCBAs to make clinical decisions based on their own assessment rather than organizational directives. Code 3.01 establishes that client interests take precedence over other considerations. Together, these codes create a framework for maintaining ethical practice within financially driven organizational structures.
Watch for several indicators: steadily increasing caseload expectations without corresponding increases in support resources, performance evaluations that weight billable hours more heavily than clinical outcomes, high turnover rates among RBTs and BCBAs, pressure to maintain or increase authorized hours for clients who are demonstrating readiness for fading, reduction in supervision hours below what is clinically indicated, and resistance from leadership when practitioners raise concerns about treatment quality. Compare your organization's practices against professional guidelines for caseload sizes, supervision ratios, and treatment planning standards. If your organization consistently pushes the boundaries of what is clinically defensible, financial pressures may be driving those decisions.
Start by documenting specific instances where you believe financial pressures are compromising clinical quality. Use internal channels first, raising concerns with your clinical supervisor, compliance officer, or clinical leadership team. Put concerns in writing to create a record. If internal channels are unresponsive, consider consulting with the BACB Ethics Department or your state licensing board. Connect with colleagues to determine whether your concerns are shared. Professional organizations and listservs can provide guidance without requiring you to identify your employer. If the situation involves clear ethical violations, you may have a reporting obligation. Throughout this process, continue to make clinical decisions that prioritize client welfare, documenting your rationale thoroughly.
PE ownership can affect RBT compensation in both directions. Some PE-backed organizations leverage their scale to offer competitive wages, benefits packages, and career advancement opportunities that smaller practices cannot match. Others treat labor cost reduction as a key lever for improving margins, resulting in lower wages, minimal benefits, and high turnover. The PE model's emphasis on cost efficiency may also lead to practices such as minimizing drive time compensation, reducing paid training hours, or classifying workers in ways that limit benefit obligations. RBT retention is directly tied to compensation and working conditions, and high turnover creates a cascade of negative effects on treatment consistency and client outcomes.
ABA shares many characteristics with other healthcare sectors that have attracted PE investment, but several features make the ABA context distinct. The client population, primarily children with autism and developmental disabilities, is particularly vulnerable. Treatment relationships in ABA are often more intensive and longer-term than in sectors like urgent care or dental practices. The field's reliance on direct service providers with relatively low barriers to entry, RBTs, creates workforce dynamics similar to home health but with higher training requirements. Additionally, ABA as a profession is relatively young, with less established regulatory infrastructure than medicine or nursing, which may provide fewer guardrails against problematic practices driven by financial incentives.
Ask about expected caseload sizes and how they are determined. Inquire about the performance metrics used to evaluate BCBAs, specifically whether clinical outcomes are weighted alongside productivity measures. Ask about the average tenure of BCBAs and RBTs at the organization. Request information about the clinical leadership structure and whether clinical leaders report to other clinicians or directly to business operations. Ask how the organization handles situations where a BCBA's clinical recommendation conflicts with what is financially optimal for the company. Inquire about the organization's supervision model and whether supervision time is protected or subject to being displaced by direct service demands. These questions will reveal more about the organization's values than any mission statement.
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Ready to go deeper? This course covers this topic with structured learning objectives and CEU credit.
Private Equity in Behavior Analysis: A Reckoning — Cody Morris · 1 BACB Ethics CEUs · $20
Take This Course →We extended these answers with research from our library — dig into the peer-reviewed studies behind the topic, in plain-English summaries written for BCBAs.
279 research articles with practitioner takeaways
239 research articles with practitioner takeaways
194 research articles with practitioner takeaways
1 BACB Ethics CEUs · $20 · BehaviorLive
Research-backed educational guide with practice recommendations
Side-by-side comparison with clinical decision framework
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.